Argenx
ARGX
#638
Rank
$31.87 B
Marketcap
$533.00
Share price
-0.62%
Change (1 day)
3.69%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Net assets

Net assets on the balance sheet as of June 2024 : $4.26 B

According to Argenx 's latest financial reports the company has $4.26 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Argenx - Net assets on balance sheet (from 2021 to 2020)

Net assets by year

Year Net assets Change
2022-12-31$$2.81 B11.03%
2021-12-31$$2.53 B23.84%
2020-12-31$$2.04 B54.4%
2019-12-31$$1.32 B87.86%
2018-12-31$$0.70 B42.09%
2017-12-31$$0.49 B608.23%
2016-12-31$$70.1 M57.57%
2015-12-31$$44.49 M-39.98%
2014-12-31$$74.13 M79.04%
2013-12-31$$41.4 M88.14%
2012-12-31$$22 M-39.25%
2011-12-31$$36.23 M166.86%
2010-12-31$$13.57 M